Kelly Rootes-Murdy1, Kara L Glazer2, Michael J Van Wert3, Francis M Mondimore3, Peter P Zandi4. 1. Department of Psychiatry & Behavioral Sciences, Johns Hopkins Mood Disorders Center, USA. 2. Department of Psychiatry & Behavioral Sciences, Johns Hopkins Mood Disorders Center, USA. Electronic address: Kglazer4@jhmi.edu. 3. Johns Hopkins Bayview Medical Center, Community Psychiatry Program, USA. 4. Department of Psychiatry & Behavioral Sciences, Johns Hopkins Mood Disorders Center, USA; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, USA.
Abstract
BACKGROUND: Medication non-adherence is a critical challenge for many patients diagnosed with mood disorders (Goodwin and Jamison, 1990). There is a need for alternative strategies that improve adherence among patients with mood disorders that are cost-effective, able to reach large patient populations, easy to implement, and that allow for communication with patients outside of in-person visits. Technology-based approaches to promote medication adherence are increasingly being explored to address this need. The aim of this paper is to provide a systematic review of the use of mobile technologies to improve medication adherence in patients with mood disorders. METHODS: A total of nine articles were identified as describing mobile technology targeting medication adherence in mood disorder populations. RESULTS: Results showed overall satisfaction and feasibility of mobile technology, and reduction in mood symptoms; however, few examined effectiveness of mobile technology improving medication adherence through randomized control trials. LIMITATIONS: Given the limited number of studies, further research is needed to determine long term effectiveness. CONCLUSIONS: Mobile technologies has the potential to improve medication adherence and can be further utilized for symptom tracking, side effects tracking, direct links to prescription refills, and provide patients with greater ownership over their treatment progress.
BACKGROUND: Medication non-adherence is a critical challenge for many patients diagnosed with mood disorders (Goodwin and Jamison, 1990). There is a need for alternative strategies that improve adherence among patients with mood disorders that are cost-effective, able to reach large patient populations, easy to implement, and that allow for communication with patients outside of in-person visits. Technology-based approaches to promote medication adherence are increasingly being explored to address this need. The aim of this paper is to provide a systematic review of the use of mobile technologies to improve medication adherence in patients with mood disorders. METHODS: A total of nine articles were identified as describing mobile technology targeting medication adherence in mood disorder populations. RESULTS: Results showed overall satisfaction and feasibility of mobile technology, and reduction in mood symptoms; however, few examined effectiveness of mobile technology improving medication adherence through randomized control trials. LIMITATIONS: Given the limited number of studies, further research is needed to determine long term effectiveness. CONCLUSIONS: Mobile technologies has the potential to improve medication adherence and can be further utilized for symptom tracking, side effects tracking, direct links to prescription refills, and provide patients with greater ownership over their treatment progress.
Authors: Sherif M Badawy; Robert M Cronin; Jane Hankins; Lori Crosby; Michael DeBaun; Alexis A Thompson; Nirmish Shah Journal: J Med Internet Res Date: 2018-07-19 Impact factor: 5.428
Authors: Jackson M Steinkamp; Nathaniel Goldblatt; Jacob T Borodovsky; Amy LaVertu; Ian M Kronish; Lisa A Marsch; Zev Schuman-Olivier Journal: JMIR Ment Health Date: 2019-03-12
Authors: Christian Rauschenberg; Anita Schick; Dusan Hirjak; Andreas Seidler; Isabell Paetzold; Christian Apfelbacher; Steffi G Riedel-Heller; Ulrich Reininghaus Journal: J Med Internet Res Date: 2021-03-10 Impact factor: 5.428
Authors: Kevin Christopher McKenna; Cindy Geoghegan; Teresa Swezey; Brian Perry; William A Wood; Virginia Nido; Steve L Morin; Brigid K Grabert; Zachary P Hallinan; Amy L Corneli Journal: JMIR Mhealth Uhealth Date: 2021-02-12 Impact factor: 4.773
Authors: Beatriz González de León; Tasmania Del Pino-Sedeño; Pedro Serrano-Pérez; Cristobalina Rodríguez Álvarez; Daniel Bejarano-Quisoboni; María M Trujillo-Martín Journal: BMC Psychiatry Date: 2022-07-20 Impact factor: 4.144